Tag: Onxeo

Onxeo encouraged by intermediate results from the first part of the DRIIV-1b study evaluating AsiDNA in combination with chemotherapy
September 18, 2019 Off

Onxeo encouraged by intermediate results from the first part of the DRIIV-1b study evaluating AsiDNA in combination with chemotherapy

By BusinessWire

Onxeo said it stabilized disease without tumor progression for two of the three treated patients who are still receiving treatment with AsiDNA™ plus carboplatin, with reaching satisfactory tolerance allowing the continuation of the study to evaluate AsiDNA™ in combination with carboplatin and paclitaxel, a reference treatment protocol for many cancers.

Onxeo clarifies its liver cancer study information
February 8, 2017 Off

Onxeo clarifies its liver cancer study information

By Dino Mustafić

Onxeo, a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, issued press release to clarify information regarding the Relive trial design and conduct and, in particular, the role of its Data Safety and Monitoring Board (DSMB).